Clinical Approach to Diarrhea
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Diarrhea
Diarrhea is one of the most common presenting complaints in clinical practice, accounting for approximately 179 million outpatient visits annually in the United States alone. Globally, diarrheal diseases remain a leading cause of morbidity and mortality, causing approximately 1.6 million deaths per year, predominantly in developing countries. In adults, acute diarrhea affects virtually everyone at some point, with the average adult experiencing 0.5 to 2 episodes per year. Chronic diarrhea affects approximately 3-5% of the population and significantly impacts quality of life, work productivity, and healthcare costs.
Definition
Diarrhea is defined as the passage of three or more loose or liquid stools per day, or more frequently than is normal for the individual. Alternatively, it can be defined as stool weight exceeding 200 grams per day in Western populations. The key distinction is a change in stool consistency (looser) and frequency (increased) from the patient’s baseline.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 14 days | Viral gastroenteritis, bacterial infection, food poisoning, medication side effects | Usually self-limiting; focus on hydration and identifying red flags |
| Persistent | 14 to 30 days | Protozoal infections (Giardia), post-infectious irritable bowel syndrome, undiagnosed chronic conditions | Warrants investigation; may represent resolving acute or emerging chronic process |
| Chronic | Greater than 30 days | Inflammatory bowel disease, irritable bowel syndrome, malabsorption syndromes, chronic infections | Requires systematic workup; significant impact on quality of life |
Classification by Character
Watery Diarrhea
Secretory: Large volume, persists with fasting, no osmotic gap. Suggests enterotoxin-producing bacteria, hormone-secreting tumors, or bile acid malabsorption.
Osmotic: Stops with fasting, high osmotic gap. Suggests lactose intolerance, sorbitol ingestion, or magnesium-containing antacids.
Inflammatory (Bloody)
Contains blood, mucus, or pus. Associated with tenesmus, urgency, and fever. Suggests invasive pathogens (Shigella, Salmonella, Campylobacter), inflammatory bowel disease, or ischemic colitis.
Fatty (Steatorrhea)
Pale, bulky, greasy, foul-smelling stools that float. Suggests malabsorption from pancreatic insufficiency, celiac disease, small intestinal bacterial overgrowth, or bile salt deficiency.
Stool Characteristics and Their Significance
| Characteristic | Description | Suggests |
|---|---|---|
| Large volume, watery | Greater than 1 liter per day, non-bloody | Small bowel origin (secretory or osmotic) |
| Small volume, frequent | Multiple small stools with urgency | Large bowel or rectal origin |
| Blood and mucus | Visible blood, mucoid material | Inflammatory process, colitis, malignancy |
| Pale, floating, greasy | Difficult to flush, oily residue | Fat malabsorption, steatorrhea |
| Nocturnal diarrhea | Wakes patient from sleep | Organic pathology (excludes functional causes) |
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Postprandial | Occurs within 30-60 minutes of eating | Gastrocolic reflex exaggeration, dumping syndrome, bile acid malabsorption |
| Morning predominant | Clustered episodes in the morning, then resolves | Irritable bowel syndrome (typically does not wake patient at night) |
| Nocturnal | Wakes patient from sleep | Organic disease: inflammatory bowel disease, diabetic autonomic neuropathy, microscopic colitis |
| Continuous | Persistent throughout the day | Secretory diarrhea, inflammatory bowel disease, malignancy |
| Intermittent | Alternates with normal bowel habits or constipation | Irritable bowel syndrome, partial bowel obstruction with overflow |
Key Concept: The Anatomical Approach
Determining the likely site of pathology guides the differential diagnosis:
- Small bowel diarrhea: Large volume, watery, periumbilical cramping, associated with malabsorption features
- Large bowel diarrhea: Small volume, frequent, associated with urgency, tenesmus, blood, and mucus
This distinction helps narrow the differential and guide investigation strategy.
Impact on Quality of Life
Beyond the Bowel
Chronic diarrhea significantly impacts patients’ lives beyond the gastrointestinal symptoms. Consider and address:
- Nutritional consequences: Weight loss, micronutrient deficiencies, protein-calorie malnutrition
- Psychological impact: Anxiety about access to bathrooms, social withdrawal, depression
- Functional limitations: Work absenteeism, travel restrictions, sleep disturbance
- Complications: Dehydration, electrolyte disturbances, perianal skin breakdown
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Diarrhea
Normal intestinal function involves a delicate balance between absorption and secretion. Each day, the gastrointestinal tract processes approximately 9-10 liters of fluid: 2 liters from oral intake and 7-8 liters from gastrointestinal secretions. The small intestine absorbs approximately 80% of this fluid, and the colon absorbs most of the remainder, resulting in only 100-200 mL of water in normal stool. Diarrhea occurs when this balance is disrupted through one or more of four fundamental mechanisms: secretory, osmotic, inflammatory, or motility-related processes.
Normal Intestinal Fluid Handling
| Component | Daily Volume | Function |
|---|---|---|
| Oral Intake | Approximately 2 liters | Exogenous fluid load |
| Salivary Secretions | 1.5 liters | Lubrication, initial digestion |
| Gastric Secretions | 2.5 liters | Acid, pepsin, intrinsic factor |
| Biliary Secretions | 0.5 liters | Bile salts for fat absorption |
| Pancreatic Secretions | 1.5 liters | Digestive enzymes, bicarbonate |
| Small Intestinal Secretions | 1 liter | Mucus, electrolytes |
| Small Bowel Absorption | 7-8 liters absorbed | Majority of fluid reabsorption |
| Colonic Absorption | 1-1.5 liters absorbed | Final water and electrolyte salvage |
| Normal Stool Output | 100-200 mL | Minimal fluid loss |
The Four Mechanisms of Diarrhea
1. Secretory Diarrhea
Mechanism: Active secretion of electrolytes and water into the intestinal lumen exceeds absorptive capacity.
Key Features:
- Large volume (often greater than 1 liter per day)
- Watery, non-bloody
- Persists with fasting
- Low stool osmotic gap (less than 50 mOsm/kg)
Examples: Cholera toxin, enterotoxigenic Escherichia coli, carcinoid syndrome, vasoactive intestinal peptide-secreting tumors (VIPomas), bile acid malabsorption
2. Osmotic Diarrhea
Mechanism: Poorly absorbed, osmotically active substances draw water into the intestinal lumen.
Key Features:
- Stops or significantly decreases with fasting
- High stool osmotic gap (greater than 125 mOsm/kg)
- Stool volume proportional to intake of offending substance
Examples: Lactose intolerance, sorbitol or mannitol ingestion, magnesium-containing antacids or laxatives, celiac disease (carbohydrate malabsorption component)
3. Inflammatory Diarrhea
Mechanism: Mucosal damage leads to exudation of blood, mucus, and protein, with impaired absorption and increased secretion.
Key Features:
- Blood and mucus in stool
- Associated fever, abdominal pain
- Fecal leukocytes or elevated fecal calprotectin
- Small, frequent stools with urgency and tenesmus
Examples: Invasive bacterial infections (Shigella, Salmonella, Campylobacter), inflammatory bowel disease, ischemic colitis, radiation colitis
4. Motility-Related Diarrhea
Mechanism: Abnormal intestinal transit time affects absorption and secretion balance.
Key Features:
- Variable presentation depending on whether transit is increased or decreased
- May alternate with constipation
- Associated neurological or systemic conditions
Examples: Diabetic autonomic neuropathy, hyperthyroidism, irritable bowel syndrome, post-surgical states (vagotomy, gastrectomy)
Clinical Tool: Stool Osmotic Gap
The stool osmotic gap helps distinguish between secretory and osmotic diarrhea:
Formula: Stool Osmotic Gap = 290 − 2 × (Stool Sodium + Stool Potassium)
- Less than 50 mOsm/kg: Secretory diarrhea (electrolyte-driven)
- Greater than 125 mOsm/kg: Osmotic diarrhea (unabsorbed solutes)
- 50-125 mOsm/kg: Mixed or indeterminate
How Specific Conditions Cause Diarrhea
| Condition | Primary Mechanism | Pathophysiological Details | Treatment Implication |
|---|---|---|---|
| Clostridioides difficile infection | Secretory and Inflammatory | Toxins A and B cause chloride secretion and mucosal inflammation; toxin B is more potent cytotoxin | Antibiotics targeting Clostridioides difficile; stop inciting antibiotics if possible |
| Celiac disease | Osmotic and Malabsorptive | Gluten-triggered autoimmune destruction of villi; reduced absorptive surface area for nutrients and fluids | Strict gluten-free diet leads to mucosal healing |
| Inflammatory bowel disease (Crohn disease, ulcerative colitis) | Inflammatory | Chronic immune-mediated mucosal damage; exudation, impaired absorption, and altered motility | Anti-inflammatory and immunomodulatory therapy |
| Bile acid malabsorption | Secretory | Unabsorbed bile acids in colon stimulate chloride and water secretion via cyclic adenosine monophosphate pathway | Bile acid sequestrants (cholestyramine, colesevelam) |
| Lactose intolerance | Osmotic | Lactase deficiency leads to unabsorbed lactose; bacterial fermentation produces gas and osmotic load | Lactose avoidance or lactase supplementation |
| Small intestinal bacterial overgrowth | Osmotic and Malabsorptive | Excess bacteria deconjugate bile salts and consume nutrients; leads to fat malabsorption and vitamin B12 deficiency | Antibiotics (rifaximin, metronidazole); address underlying cause |
| Hyperthyroidism | Motility-related | Increased thyroid hormone accelerates gastrointestinal transit; reduced absorption time | Treatment of underlying thyroid disorder |
| Carcinoid syndrome | Secretory | Serotonin and other vasoactive substances stimulate intestinal secretion and motility | Somatostatin analogs (octreotide); tumor debulking |
| Microscopic colitis | Secretory and Inflammatory | Lymphocytic or collagenous inflammation impairs colonic absorption; often associated with medications | Budesonide; discontinue offending medications |
| Diabetic autonomic neuropathy | Motility-related | Autonomic dysfunction causes erratic motility; often with bacterial overgrowth component | Antidiarrheals; treat bacterial overgrowth if present |
Enterocyte Physiology: Absorption and Secretion
| Process | Location | Mechanism | Clinical Relevance |
|---|---|---|---|
| Sodium-coupled absorption | Villus enterocytes | Sodium-glucose cotransporter (SGLT1) and sodium-amino acid cotransporters drive water absorption | Basis for oral rehydration therapy; glucose enhances sodium and water absorption |
| Electroneutral NaCl absorption | Small intestine and colon | Coupled sodium-hydrogen and chloride-bicarbonate exchangers | Impaired in inflammatory conditions |
| Chloride secretion | Crypt enterocytes | Cystic fibrosis transmembrane conductance regulator (CFTR) channel mediates chloride secretion | Target of cholera toxin and heat-labile Escherichia coli toxin via cyclic adenosine monophosphate activation |
| Colonic salvage | Colon | Epithelial sodium channels (ENaC) absorb sodium; short-chain fatty acids enhance water absorption | Explains benefit of fiber and probiotics; aldosterone enhances absorption |
Often Overlooked Mechanism: Bile Acid Malabsorption
Bile acid malabsorption is an underdiagnosed cause of chronic watery diarrhea, affecting up to 30% of patients previously labeled with diarrhea-predominant irritable bowel syndrome. It occurs when the terminal ileum fails to reabsorb bile acids, allowing them to reach the colon where they stimulate secretion. Consider this diagnosis in patients with:
- Prior cholecystectomy (postcholecystectomy diarrhea)
- Ileal resection or Crohn disease affecting the terminal ileum
- Radiation enteritis
- Idiopathic bile acid malabsorption (primary)
A therapeutic trial of bile acid sequestrant (cholestyramine 4g twice daily) can be both diagnostic and therapeutic.
Pathophysiology of Diarrhea Complications
| Complication | Mechanism | Clinical Manifestations |
|---|---|---|
| Dehydration | Fluid losses exceed intake; impaired renal compensation in severe cases | Tachycardia, hypotension, decreased urine output, altered mental status |
| Hypokalemia | Direct potassium loss in stool; secondary hyperaldosteronism from volume depletion | Muscle weakness, cardiac arrhythmias, paralytic ileus |
| Metabolic acidosis | Loss of bicarbonate in stool (normal anion gap acidosis) | Kussmaul breathing, fatigue, confusion |
| Hypomagnesemia | Impaired magnesium absorption; increased intestinal losses | Muscle cramps, tetany, cardiac arrhythmias, refractory hypokalemia |
| Malnutrition | Reduced absorption of macronutrients and micronutrients | Weight loss, muscle wasting, specific vitamin deficiencies |
3. History Taking
A comprehensive approach to eliciting the Diarrhea history
Red Flags — Require Urgent Evaluation
- Bloody diarrhea (dysentery) — Invasive infection, inflammatory bowel disease, ischemic colitis
- Severe dehydration — Hemodynamic compromise, requires immediate fluid resuscitation
- High fever (greater than 38.5°C) — Invasive bacterial infection, toxic megacolon
- Severe abdominal pain — Ischemic bowel, perforation, toxic megacolon
- Recent antibiotic use — Clostridioides difficile infection
- Immunocompromised state — Opportunistic infections, atypical presentations
- Age greater than 70 years — Higher risk of complications, ischemic colitis
- Symptoms greater than 7 days without improvement — Requires investigation beyond supportive care
Systematic History: The “DIARRHEA” Approach
Use the mnemonic “DIARRHEA” to ensure comprehensive history taking:
- D — Duration and onset: When did it start? Sudden or gradual? Acute, persistent, or chronic?
- I — Infectious exposures: Sick contacts? Recent travel? Food history? Water source?
- A — Appearance of stool: Watery, bloody, mucoid, fatty? Volume? Color?
- R — Related symptoms: Fever, vomiting, abdominal pain, weight loss, joint pain, rash?
- R — Risk factors: Immunocompromised? Recent hospitalization? Antibiotics?
- H — Habits and diet: Lactose intake? Artificial sweeteners? Alcohol? Caffeine?
- E — Exacerbating and relieving factors: Worse with eating? Better with fasting? Nocturnal symptoms?
- A — Associated medical history: Prior gastrointestinal surgery? Diabetes? Thyroid disease? Family history of inflammatory bowel disease or celiac disease?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Infectious gastroenteritis | Acute onset, sick contacts, food exposure | “Has anyone else who ate the same food become ill? Have you traveled recently?” |
| Clostridioides difficile infection | Recent antibiotics, hospitalization, watery diarrhea | “Have you taken any antibiotics in the past 3 months? Have you been hospitalized recently?” |
| Inflammatory bowel disease | Bloody stools, weight loss, extraintestinal symptoms | “Do you see blood or mucus in your stool? Have you had joint pain, mouth ulcers, or skin problems?” |
| Irritable bowel syndrome | Chronic, alternating pattern, no nocturnal symptoms | “Does the diarrhea ever wake you from sleep? Is it associated with abdominal pain that improves after a bowel movement?” |
| Celiac disease | Steatorrhea, weight loss, iron deficiency | “Are your stools pale, bulky, or difficult to flush? Do you have any family history of celiac disease?” |
| Lactose intolerance | Symptoms after dairy, bloating, gas | “Do you notice symptoms specifically after consuming milk, cheese, or ice cream?” |
| Bile acid malabsorption | Watery, urgent, postprandial | “Have you had your gallbladder removed? Do you have Crohn disease or prior ileal surgery?” |
| Microscopic colitis | Chronic watery diarrhea, often in older women | “Are you taking any nonsteroidal anti-inflammatory drugs, proton pump inhibitors, or selective serotonin reuptake inhibitors regularly?” |
| Small intestinal bacterial overgrowth | Bloating, steatorrhea, history of surgery or dysmotility | “Do you have significant bloating or excessive gas? Have you had abdominal surgery or do you have diabetes?” |
| Hyperthyroidism | Weight loss despite good appetite, heat intolerance | “Have you noticed weight loss, tremor, palpitations, or feeling hot when others are comfortable?” |
| Ischemic colitis | Elderly, cardiovascular disease, sudden onset with pain | “Did the pain come on suddenly? Do you have a history of heart disease, atrial fibrillation, or peripheral vascular disease?” |
| Colorectal malignancy | Change in bowel habit, rectal bleeding, weight loss | “Have you noticed any unintentional weight loss? Any change in the caliber of your stool? Any family history of colon cancer?” |
Characterizing the Stool
Essential Stool Questions
Ask patients to describe their stool in detail:
- Frequency: “How many bowel movements per day? Is this different from your normal?”
- Volume: “Would you describe it as a large amount or small, frequent amounts?”
- Consistency: “Is it watery like water, mushy, or formed but loose?”
- Blood: “Is there blood? Is it bright red, dark, or mixed into the stool?”
- Mucus: “Do you see any mucus or slime?”
- Fat: “Does the stool float? Is it difficult to flush? Is there an oily residue?”
- Odor: “Has the smell changed? Is it particularly foul?”
Medication and Dietary History
Medications That Cause Diarrhea
- Antibiotics — Direct effect on gut flora; risk of Clostridioides difficile
- Proton pump inhibitors — Increased risk of Clostridioides difficile and small intestinal bacterial overgrowth
- Nonsteroidal anti-inflammatory drugs — Mucosal damage, microscopic colitis
- Metformin — Dose-related, often improves with time
- Selective serotonin reuptake inhibitors — Increased intestinal motility
- Magnesium-containing antacids — Osmotic effect
- Colchicine — Dose-related gastrointestinal toxicity
- Chemotherapy agents — Mucosal damage, altered motility
- Immunosuppressants (mycophenolate) — Direct gastrointestinal toxicity
- Orlistat — Fat malabsorption (mechanism of action)
Dietary Causes to Explore
- Lactose: Milk, cheese, ice cream, hidden in processed foods
- Fructose: Fruit juices, honey, high-fructose corn syrup
- Sugar alcohols: Sorbitol, mannitol, xylitol in sugar-free products
- Caffeine: Coffee, tea, energy drinks — stimulates motility
- Alcohol: Direct mucosal irritation, altered motility
- Artificial sweeteners: Aspartame, sucralose in some individuals
- Gluten: Wheat, barley, rye products
- FODMAPs: Fermentable carbohydrates in various foods
Social, Occupational, and Travel History
| Category | Key Questions | Relevant Conditions |
|---|---|---|
| Travel history | Recent travel to endemic areas? Duration and timing? | Traveler’s diarrhea, Giardia, Entamoeba, typhoid fever, tropical sprue |
| Food exposures | Undercooked meat, eggs, seafood? Unpasteurized dairy? Street food? | Salmonella, Campylobacter, Vibrio, Listeria, hepatitis A |
| Water source | Well water? Untreated water while camping or traveling? | Giardia, Cryptosporidium, bacterial pathogens |
| Sexual history | Men who have sex with men? Anal receptive intercourse? | Proctitis (gonorrhea, chlamydia, herpes), Giardia, Entamoeba |
| Occupation | Daycare worker? Healthcare worker? Food handler? | Increased exposure to enteric pathogens; public health implications |
| Animal contact | Farm animals? Reptiles? New pets? | Salmonella, Campylobacter, Cryptosporidium |
| Immune status | HIV status? Transplant recipient? Chemotherapy? Immunosuppressants? | Opportunistic infections (Cryptosporidium, Microsporidium, cytomegalovirus, Mycobacterium avium complex) |
Clinical Tool: Incubation Period Clues
The time from exposure to symptom onset can suggest the etiology:
- Less than 6 hours: Preformed toxin (Staphylococcus aureus, Bacillus cereus emetic type) — primarily vomiting
- 6-24 hours: Toxin-producing bacteria (Clostridium perfringens, Bacillus cereus diarrheal type)
- 1-3 days: Viral gastroenteritis (norovirus, rotavirus), enterotoxigenic Escherichia coli
- 3-7 days: Invasive bacteria (Salmonella, Campylobacter, Shigella)
- 1-2 weeks: Protozoal infections (Giardia, Cryptosporidium)
4. Physical Examination
A systematic head-to-toe approach for Diarrhea
Systematic Framework: Use the “Head to Extremities” approach with particular attention to hydration status, nutritional state, and signs of underlying systemic disease in patients presenting with diarrhea.
General Inspection
- Appearance: Does the patient appear acutely ill, chronically unwell, or comfortable? Signs of distress?
- Nutritional status: Cachexia, muscle wasting, temporal wasting — suggests chronic malabsorption or malignancy
- Hydration status: Dry mucous membranes, decreased skin turgor, sunken eyes
- Mental status: Lethargy or confusion may indicate severe dehydration or electrolyte disturbance
- Pallor: May suggest anemia from chronic blood loss or malabsorption
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) or hypothermia | Fever suggests invasive infection or inflammatory process; hypothermia may indicate sepsis in elderly |
| Heart Rate | Tachycardia (greater than 100 beats per minute) | Early sign of dehydration; may also indicate fever, pain, or sepsis |
| Blood Pressure | Hypotension or orthostatic changes | Orthostatic drop (systolic decrease greater than 20 mmHg on standing) indicates significant volume depletion |
| Respiratory Rate | Tachypnea | May indicate metabolic acidosis (Kussmaul breathing) from bicarbonate losses |
| Weight | Compare to baseline if available | Acute weight loss suggests fluid loss; chronic weight loss suggests malabsorption or malignancy |
Hydration Assessment
| Finding | Mild Dehydration (3-5%) | Moderate Dehydration (6-9%) | Severe Dehydration (≥10%) |
|---|---|---|---|
| Mental status | Normal | Irritable or lethargic | Lethargic or unconscious |
| Thirst | Slight increase | Moderately increased | Unable to drink |
| Heart rate | Normal | Increased | Increased and weak |
| Blood pressure | Normal | Normal to low | Low, orthostatic |
| Skin turgor | Normal | Decreased | Markedly decreased |
| Mucous membranes | Slightly dry | Dry | Very dry, cracked |
| Urine output | Decreased | Oliguria | Anuria |
| Capillary refill | Normal (less than 2 seconds) | Delayed (2-3 seconds) | Very delayed (greater than 3 seconds) |
Head, Eyes, and Mouth Examination
Eyes
Sunken eyes: Significant dehydration
Pallor of conjunctivae: Anemia (chronic blood loss, B12 or iron deficiency)
Jaundice: Consider hepatobiliary disease
Episcleritis or uveitis: Extraintestinal manifestation of inflammatory bowel disease
Mouth and Oral Cavity
Dry mucous membranes: Dehydration
Angular cheilitis: Iron, riboflavin, or zinc deficiency
Glossitis: B12, folate, or iron deficiency
Aphthous ulcers: Inflammatory bowel disease, celiac disease
Oral thrush: Immunocompromised state
Neck Examination
- Thyroid: Goiter or nodules — hyperthyroidism can cause diarrhea
- Lymphadenopathy: Consider lymphoma, infection, or metastatic disease
- Jugular venous pressure: Usually low in dehydration; elevated suggests cardiac cause of edema
Abdominal Examination
Inspection
- Distension: May indicate obstruction, ascites, or severe ileus
- Surgical scars: Prior surgery (cholecystectomy, bowel resection) may explain symptoms
- Visible peristalsis: Suggests obstruction
- Fistulae or stomas: Note location and output
Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Hyperactive bowel sounds | Frequent, high-pitched, rushing sounds | Gastroenteritis, early obstruction, inflammatory bowel disease flare |
| Absent bowel sounds | No sounds heard over 2-3 minutes | Ileus, peritonitis, late obstruction |
| Normal bowel sounds | Intermittent gurgling every 5-15 seconds | Does not exclude significant pathology |
Palpation
- Tenderness: Localized tenderness may indicate specific pathology; diffuse tenderness suggests generalized inflammation
- Guarding and rigidity: Peritoneal irritation — requires urgent evaluation
- Masses: May represent tumor, abscess, or inflammatory mass (Crohn disease)
- Hepatomegaly: Consider metastatic disease, hepatobiliary pathology
- Splenomegaly: May suggest portal hypertension, lymphoma, or infection
- Right lower quadrant tenderness: Terminal ileitis (Crohn disease), appendicitis, cecal pathology
- Left lower quadrant tenderness: Sigmoid pathology, diverticulitis, inflammatory bowel disease
Percussion
- Tympany: Normal or increased with gas-filled loops (obstruction)
- Dullness: Ascites (shifting dullness), masses, organomegaly
Rectal Examination
Essential Component
The rectal examination is crucial in evaluating diarrhea and should not be omitted:
- Perianal inspection: Fissures, fistulae, skin tags (Crohn disease), hemorrhoids, excoriation
- Digital examination: Sphincter tone, masses, tenderness, stool character
- Stool appearance: Blood, mucus, melena, pale stool
- Fecal impaction: Overflow diarrhea around impacted stool
Skin and Extremities
Skin Findings
Erythema nodosum: Tender red nodules on shins — inflammatory bowel disease, infections
Pyoderma gangrenosum: Ulcerating lesions — inflammatory bowel disease
Dermatitis herpetiformis: Intensely pruritic vesicular rash — celiac disease
Flushing: Episodic facial flushing — carcinoid syndrome
Acanthosis nigricans: Velvety hyperpigmentation — associated with gastrointestinal malignancy
Skin turgor: Test on forearm or sternum in adults for dehydration
Extremities
Peripheral edema: Hypoalbuminemia from protein-losing enteropathy or malnutrition
Clubbing: Inflammatory bowel disease, malabsorption, malignancy
Arthritis: Joint swelling — inflammatory bowel disease, reactive arthritis, Whipple disease
Koilonychia: Spoon-shaped nails — iron deficiency
Muscle wasting: Chronic malnutrition or malabsorption
Other Systems to Examine
| System | Findings to Look For | Associated Conditions |
|---|---|---|
| Cardiovascular | Tachycardia, hypotension, heart murmurs | Dehydration; endocarditis in invasive Salmonella |
| Respiratory | Tachypnea, Kussmaul breathing | Metabolic acidosis from bicarbonate loss |
| Neurological | Peripheral neuropathy, ataxia, cognitive changes | B12 deficiency (chronic diarrhea), Whipple disease |
| Musculoskeletal | Sacroiliitis, peripheral arthritis | Inflammatory bowel disease, reactive arthritis |
Expected Findings by Etiology
| Condition | General Appearance | Abdominal Findings | Other Findings |
|---|---|---|---|
| Acute viral gastroenteritis | Mild dehydration, low-grade fever | Diffuse mild tenderness, hyperactive bowel sounds | Usually unremarkable |
| Clostridioides difficile colitis | May appear ill, fever | Lower abdominal tenderness, distension if severe | Recent hospitalization, antibiotic exposure history |
| Inflammatory bowel disease | May have weight loss, pallor | Tenderness (right lower quadrant in Crohn, left in ulcerative colitis), possible mass | Extraintestinal: arthritis, skin lesions, uveitis, oral ulcers |
| Celiac disease | May appear malnourished, short stature | Often unremarkable, mild distension | Dermatitis herpetiformis, glossitis, dental enamel defects |
| Hyperthyroidism | Anxious, thin, tremor | Usually unremarkable | Tachycardia, lid lag, goiter, warm moist skin, fine tremor |
| Carcinoid syndrome | Flushing episodes | May have hepatomegaly (metastases) | Right-sided heart murmur (tricuspid regurgitation), telangiectasias |
| Irritable bowel syndrome | Well-appearing, no weight loss | May have mild tenderness, often normal | No systemic features, no nocturnal symptoms |
Important Teaching Point
Normal examination is common! Many causes of diarrhea present with entirely normal physical examination findings, including:
- Irritable bowel syndrome
- Microscopic colitis
- Bile acid malabsorption
- Mild celiac disease
- Lactose intolerance
- Early inflammatory bowel disease
- Small intestinal bacterial overgrowth
A normal examination does not exclude significant pathology. The physical examination is most useful for assessing hydration status, detecting complications, and identifying clues to systemic disease — not for definitively diagnosing the cause of diarrhea.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Diarrhea (Duration: Less than 14 days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70-80%) | Viral gastroenteritis (norovirus, rotavirus) | Watery diarrhea, vomiting, low-grade fever, self-limiting over 1-3 days | Severe dehydration, elderly or immunocompromised |
| COMMON | Bacterial food poisoning (toxin-mediated) | Rapid onset after eating, vomiting predominant, multiple people affected | High fever, bloody stool (suggests invasive) |
| COMMON | Medication-induced diarrhea | Temporal relationship with starting new medication, resolves with discontinuation | Bloody diarrhea, fever (consider Clostridioides difficile) |
| LESS COMMON (approximately 15-20%) | Bacterial enteritis (Campylobacter, Salmonella, Shigella) | Fever, bloody or mucoid stool, abdominal cramps, food exposure | High fever, severe abdominal pain, signs of sepsis |
| LESS COMMON | Traveler’s diarrhea (enterotoxigenic Escherichia coli) | Recent travel to endemic area, watery diarrhea, abdominal cramps | Bloody stool, fever, prolonged duration |
| LESS COMMON | Clostridioides difficile infection | Recent antibiotic use, hospitalization, watery diarrhea, abdominal pain | Severe abdominal pain, distension, fever, leukocytosis |
| UNCOMMON BUT SERIOUS (approximately 5%) | Ischemic colitis | Elderly, cardiovascular disease, sudden onset left-sided pain, bloody diarrhea | Peritoneal signs, hemodynamic instability |
| UNCOMMON BUT SERIOUS | Inflammatory bowel disease (initial presentation) | Bloody diarrhea, weight loss, extraintestinal manifestations | Toxic megacolon, severe bleeding, perforation |
| UNCOMMON BUT SERIOUS | Appendicitis (atypical presentation) | Right lower quadrant pain, fever, diarrhea may be early symptom | Peritoneal signs, rebound tenderness |
Chronic Diarrhea (Duration: Greater than 30 days)
Step-by-Step Approach to Chronic Diarrhea:
- Step 1: Rule out obvious causes — Is the patient on medications known to cause diarrhea? Are there dietary factors (lactose, artificial sweeteners, excessive caffeine)?
- Step 2: Classify by stool characteristics — Is it watery (secretory vs osmotic), inflammatory (bloody/mucoid), or fatty (steatorrhea)?
- Step 3: Consider the “Big Five” common causes — Irritable bowel syndrome, inflammatory bowel disease, microscopic colitis, celiac disease, and bile acid malabsorption
- Step 4: Investigate for less common causes if initial workup negative
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Irritable bowel syndrome (diarrhea-predominant) | 25-30% | Abdominal pain relieved by defecation, no nocturnal symptoms, no weight loss, normal inflammatory markers |
| COMMON | Inflammatory bowel disease (ulcerative colitis, Crohn disease) | 10-15% | Bloody stool, weight loss, nocturnal symptoms, extraintestinal manifestations, elevated inflammatory markers |
| COMMON | Microscopic colitis | 10-15% | Older patients (especially women), watery non-bloody diarrhea, often associated with NSAIDs or PPIs, normal colonoscopy but abnormal biopsy |
| COMMON | Bile acid malabsorption | 10-15% | Watery, urgent, postprandial diarrhea; history of cholecystectomy, ileal disease, or idiopathic; responds to bile acid sequestrants |
| COMMON | Celiac disease | 5-10% | Steatorrhea, iron deficiency, weight loss, family history, associated autoimmune conditions |
| LESS COMMON | Small intestinal bacterial overgrowth | 5-10% | Bloating, flatulence, history of abdominal surgery or dysmotility, diabetes, B12 deficiency |
| LESS COMMON | Chronic infections (Giardia, Cryptosporidium) | 3-5% | Travel history, camping/hiking, immunocompromised, bloating, flatulence |
| LESS COMMON | Lactose intolerance | Variable by population | Symptoms after dairy intake, bloating, flatulence, resolves with lactose avoidance |
| LESS COMMON | Chronic pancreatitis | 3-5% | Steatorrhea, epigastric pain, history of alcohol use or recurrent pancreatitis, diabetes |
| UNCOMMON | Colorectal carcinoma | 1-3% | Change in bowel habit, rectal bleeding, weight loss, iron deficiency anemia, age greater than 50 |
| UNCOMMON | Hyperthyroidism | 1-2% | Weight loss despite good appetite, heat intolerance, tremor, tachycardia, goiter |
| UNCOMMON | Neuroendocrine tumors (carcinoid, VIPoma, gastrinoma) | Less than 1% | Secretory diarrhea, flushing (carcinoid), severe watery diarrhea (VIPoma), peptic ulcers (gastrinoma) |
| UNCOMMON | Diabetic autonomic neuropathy | 1-2% | Long-standing diabetes, other autonomic symptoms (orthostatic hypotension, gastroparesis), nocturnal diarrhea |
Anatomical Approach to Chronic Diarrhea
Small Bowel
Celiac disease
Small intestinal bacterial overgrowth
Crohn disease (small bowel)
Giardiasis
Whipple disease
Tropical sprue
Lymphoma
Large Bowel
Ulcerative colitis
Crohn disease (colonic)
Microscopic colitis
Colorectal carcinoma
Ischemic colitis
Radiation colitis
Diverticular disease
Pancreaticobiliary
Chronic pancreatitis
Pancreatic carcinoma
Bile acid malabsorption
Postcholecystectomy diarrhea
Primary biliary cholangitis
Cystic fibrosis
Systemic/Functional
Irritable bowel syndrome
Hyperthyroidism
Diabetic enteropathy
Neuroendocrine tumors
Systemic sclerosis
Amyloidosis
Drug-Induced Diarrhea
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Antibiotics (all classes) | Disruption of gut microbiome; direct mucosal effects | Onset during or shortly after course; may be Clostridioides difficile | Days to weeks; may persist if Clostridioides difficile |
| Metformin | Increased intestinal glucose utilization; bile acid malabsorption | Dose-related; often improves over time; may be osmotic | Days to weeks |
| Proton pump inhibitors | Altered gut microbiome; increased risk of infections; microscopic colitis | May develop after months of use; increases Clostridioides difficile risk | Variable; weeks if microscopic colitis |
| Nonsteroidal anti-inflammatory drugs | Mucosal damage; microscopic colitis; exacerbation of inflammatory bowel disease | May cause enteropathy, colitis, or exacerbate existing conditions | Days to weeks |
| Selective serotonin reuptake inhibitors | Increased serotonin in gut stimulates motility | Usually mild; may improve with continued use | Days |
| Magnesium-containing antacids and supplements | Osmotic effect of poorly absorbed magnesium | Dose-related; watery diarrhea | Days |
| Colchicine | Direct gastrointestinal toxicity | Dose-related; often first sign of toxicity | Days |
| Orlistat | Fat malabsorption (mechanism of action) | Steatorrhea, oily spotting; worse with high-fat meals | Immediate upon stopping |
| Mycophenolate mofetil | Direct gastrointestinal toxicity | May mimic inflammatory bowel disease; dose-related | Weeks |
| Chemotherapy agents | Mucosal damage; altered motility | Often severe; may require dose modification | Variable; may persist |
| Immune checkpoint inhibitors | Immune-mediated colitis | May be severe; mimics inflammatory bowel disease | May require steroids; weeks to months |
| Olmesartan | Sprue-like enteropathy | Severe diarrhea, weight loss, villous atrophy | Weeks to months |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Watery diarrhea after antibiotics | Clostridioides difficile infection | Stool PCR or toxin assay |
| Bloody diarrhea with fever | Invasive bacterial infection or inflammatory bowel disease | Stool culture, inflammatory markers, consider colonoscopy |
| Chronic watery diarrhea, normal colonoscopy | Microscopic colitis or bile acid malabsorption | Colonic biopsies; trial of bile acid sequestrant |
| Steatorrhea with weight loss | Celiac disease or pancreatic insufficiency | Tissue transglutaminase antibodies, fecal elastase |
| Diarrhea worse after dairy | Lactose intolerance | Trial of lactose elimination or lactose breath test |
| Postprandial urgent diarrhea after cholecystectomy | Bile acid malabsorption | Therapeutic trial of cholestyramine |
| Diarrhea with bloating and flatulence | Small intestinal bacterial overgrowth or carbohydrate malabsorption | Glucose or lactulose breath test |
| Diarrhea that does not wake patient at night | Irritable bowel syndrome (functional) | Rome IV criteria; limited workup if no alarm features |
| Elderly patient with sudden bloody diarrhea and abdominal pain | Ischemic colitis | CT angiography or colonoscopy (with caution) |
| Diarrhea with flushing episodes | Carcinoid syndrome | 24-hour urine 5-HIAA, chromogranin A |
| Diarrhea with weight loss, tachycardia, tremor | Hyperthyroidism | Thyroid function tests (TSH, free T4) |
| HIV patient with chronic watery diarrhea | Opportunistic infection (Cryptosporidium, Microsporidium, cytomegalovirus) | Specialized stool studies, colonoscopy with biopsies |
Differentiating Functional from Organic Diarrhea
Features suggesting organic (non-functional) disease that require investigation:
- Nocturnal diarrhea (wakes patient from sleep)
- Unintentional weight loss (greater than 5% body weight)
- Blood in stool
- Fever
- Anemia or elevated inflammatory markers
- Age greater than 50 with new symptoms
- Family history of colorectal cancer or inflammatory bowel disease
- Progressive or worsening symptoms
The absence of all these features makes functional diarrhea (irritable bowel syndrome) more likely.
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Acute Diarrhea: When to Investigate
Most Acute Diarrhea Does Not Require Investigation
Investigation is indicated when:
- Duration greater than 7 days without improvement
- Bloody diarrhea or dysentery
- High fever (greater than 38.5°C)
- Severe dehydration requiring intravenous fluids
- Recent antibiotic use (concern for Clostridioides difficile)
- Immunocompromised patient
- Recent hospitalization
- Elderly patient (greater than 70 years)
- Public health concern (food handler, outbreak investigation)
Baseline Investigations for Acute Diarrhea (When Indicated)
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Assess for infection, anemia, hemoconcentration | Leukocytosis (infection), eosinophilia (parasites), anemia (blood loss), elevated hematocrit (dehydration) | Leukocytosis with left shift suggests bacterial infection |
| Basic metabolic panel | Assess electrolytes, renal function, hydration | Hypokalemia, hyponatremia, elevated creatinine, metabolic acidosis (low bicarbonate) | Guides fluid and electrolyte replacement |
| Stool culture | Identify bacterial pathogens | Salmonella, Shigella, Campylobacter, Escherichia coli O157:H7 | Request specific organisms if suspected; routine culture misses many pathogens |
| Stool ova and parasites | Identify parasitic infections | Giardia, Cryptosporidium, Entamoeba | Three samples increase sensitivity; consider Giardia antigen (more sensitive) |
| Clostridioides difficile testing | Diagnose Clostridioides difficile infection | Positive PCR or toxin assay | Only test unformed stool; do not test as “cure” — PCR remains positive weeks after treatment |
| Fecal leukocytes or lactoferrin | Screen for inflammatory diarrhea | Presence suggests invasive infection or inflammatory bowel disease | Lactoferrin is more sensitive and stable than leukocyte microscopy |
Baseline Investigations for Chronic Diarrhea
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia, infection, eosinophilia | Iron deficiency anemia (celiac, malignancy), macrocytic anemia (B12 deficiency), eosinophilia (parasites, eosinophilic gastroenteritis) | Examine peripheral smear if abnormal |
| Comprehensive metabolic panel | Assess nutritional status, liver and kidney function | Low albumin (protein loss), electrolyte abnormalities, elevated liver enzymes | Hypoalbuminemia suggests protein-losing enteropathy or malnutrition |
| C-reactive protein and erythrocyte sedimentation rate | Screen for inflammatory conditions | Elevated values suggest inflammatory bowel disease or infection | Normal values make inflammatory bowel disease less likely but do not exclude it |
| Thyroid-stimulating hormone | Screen for hyperthyroidism | Low TSH with elevated free T4 | Simple, inexpensive test; should be routine in chronic diarrhea workup |
| Tissue transglutaminase IgA antibody | Screen for celiac disease | Positive result requires confirmation with duodenal biopsy | Check total IgA; 2-3% of celiac patients are IgA deficient (false negative) |
| Fecal calprotectin | Distinguish inflammatory from functional diarrhea | Greater than 50-100 µg/g suggests inflammation; greater than 250 µg/g strongly suggests inflammatory bowel disease | Very useful for triaging colonoscopy; not specific for inflammatory bowel disease |
| Stool ova and parasites (×3) | Exclude chronic parasitic infection | Giardia, Cryptosporidium, Strongyloides | Giardia antigen is more sensitive than microscopy |
Targeted Investigations by Suspected Etiology
If Suspecting Inflammatory Bowel Disease
First-Line Tests
- Fecal calprotectin: Greater than 250 µg/g strongly suggests active inflammation
- C-reactive protein: Elevated in active disease, useful for monitoring
- Complete blood count: Anemia, thrombocytosis, leukocytosis
- Albumin: Low in severe disease
Definitive Tests
- Colonoscopy with biopsies: Gold standard; assess extent and severity
- Upper endoscopy: If upper gastrointestinal symptoms or suspected Crohn disease
- MR or CT enterography: Small bowel Crohn disease, strictures, fistulae
- Capsule endoscopy: Small bowel mucosal disease if enterography negative
If Suspecting Celiac Disease
First-Line Tests
- Tissue transglutaminase IgA: Sensitivity greater than 95% in untreated disease
- Total IgA: To exclude IgA deficiency (causes false negative)
- Deamidated gliadin peptide IgG: Use if IgA deficient
Confirmatory Tests
- Duodenal biopsy: At least 4-6 biopsies from duodenum; look for villous atrophy, crypt hyperplasia, intraepithelial lymphocytosis
- HLA-DQ2/DQ8 testing: Negative result essentially excludes celiac disease; useful when diagnosis uncertain
If Suspecting Malabsorption
Pancreatic Insufficiency
- Fecal elastase-1: Less than 200 µg/g suggests insufficiency; less than 100 µg/g indicates severe insufficiency
- CT or MRI pancreas: Assess for chronic pancreatitis, calcifications, ductal changes
- Secretin-stimulated MRCP: Functional assessment of pancreatic function
Small Bowel Causes
- Vitamin B12 and folate: B12 low in terminal ileal disease or bacterial overgrowth
- Iron studies: Iron deficiency suggests proximal small bowel disease
- 25-hydroxyvitamin D: Low in fat malabsorption
- Prothrombin time: Prolonged in vitamin K malabsorption
If Suspecting Small Intestinal Bacterial Overgrowth
Diagnostic Tests
- Glucose hydrogen breath test: Rise greater than 20 ppm above baseline within 90 minutes suggests small intestinal bacterial overgrowth
- Lactulose hydrogen breath test: Alternative but less specific
- Small bowel aspirate culture: Gold standard but invasive; greater than 10³ colony-forming units per mL diagnostic
Supporting Tests
- Vitamin B12: Often low (consumed by bacteria)
- Folate: May be high (produced by bacteria)
- D-xylose absorption test: Abnormal suggests small bowel mucosal disease or bacterial overgrowth
If Suspecting Bile Acid Malabsorption
| Test | Description | Interpretation | Availability |
|---|---|---|---|
| Therapeutic trial of bile acid sequestrant | Cholestyramine 4g twice daily for 2 weeks | Response to treatment confirms diagnosis | Widely available; practical first-line approach |
| SeHCAT scan | Nuclear medicine scan measuring bile acid retention | Less than 15% retention at 7 days indicates malabsorption; less than 5% severe | Limited availability (mainly Europe) |
| Serum 7α-hydroxy-4-cholesten-3-one (C4) | Marker of bile acid synthesis | Elevated levels indicate increased synthesis to compensate for losses | Limited availability; specialized laboratories |
| Fecal bile acids | 48-hour stool collection measuring bile acid excretion | Elevated excretion confirms diagnosis | Cumbersome; rarely used clinically |
Comprehensive Stool Analysis
| Test | What It Measures | Clinical Utility | Key Values |
|---|---|---|---|
| Fecal calprotectin | Neutrophil-derived protein indicating intestinal inflammation | Distinguishes inflammatory from functional disorders; monitors inflammatory bowel disease activity | Less than 50 µg/g normal; greater than 250 µg/g likely inflammatory bowel disease |
| Fecal fat (72-hour collection) | Quantitative fat excretion | Confirms steatorrhea | Greater than 7 g/day on 100g fat diet indicates malabsorption |
| Fecal elastase-1 | Pancreatic enzyme in stool | Screens for pancreatic exocrine insufficiency | Less than 200 µg/g abnormal; less than 100 µg/g severe insufficiency |
| Stool osmolality and electrolytes | Sodium, potassium, calculated osmotic gap | Distinguishes secretory from osmotic diarrhea | Gap less than 50: secretory; Gap greater than 125: osmotic |
| Stool pH | Acidity of stool | Suggests carbohydrate malabsorption if low | Less than 5.5 suggests carbohydrate fermentation |
| Fecal occult blood | Hidden blood in stool | Screens for gastrointestinal bleeding | Positive requires further investigation |
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
When diagnosis is unclear after initial workup, empiric treatment trials can serve as diagnostic tools. Response to therapy supports the diagnosis.
- Bile acid sequestrant trial: Cholestyramine 4g twice daily for 2 weeks — tests for bile acid malabsorption (particularly if postcholecystectomy or ileal disease)
- Lactose elimination trial: Strict lactose-free diet for 2-3 weeks — tests for lactose intolerance
- Antibiotic trial for small intestinal bacterial overgrowth: Rifaximin 550mg three times daily for 14 days — tests for small intestinal bacterial overgrowth
- Proton pump inhibitor trial: If suspecting gastrinoma or eosinophilic esophagitis with diarrhea
- Pancreatic enzyme supplementation: Trial of pancrelipase with meals — tests for pancreatic insufficiency if fecal elastase borderline
- Gluten-free diet trial: Only if serologies and biopsy equivocal; strict elimination for 4-6 weeks
When to Perform Colonoscopy
| Indication | Rationale | Key Points |
|---|---|---|
| Chronic diarrhea with alarm features | Exclude colorectal cancer, inflammatory bowel disease | Alarm features: rectal bleeding, weight loss, anemia, age greater than 50 |
| Chronic watery diarrhea | Obtain biopsies for microscopic colitis | Mucosa appears normal; diagnosis requires histology |
| Elevated fecal calprotectin | Evaluate for inflammatory bowel disease | Obtain biopsies from multiple segments |
| Bloody diarrhea | Assess for colitis (infectious, inflammatory, ischemic) | May need to defer if fulminant colitis suspected |
| Chronic diarrhea unresponsive to empiric therapy | Exclude occult pathology | Important to biopsy even if mucosa appears normal |
Key Point: Always Biopsy
When performing colonoscopy for chronic diarrhea, always obtain biopsies from multiple colonic segments (right and left colon at minimum), even if the mucosa appears macroscopically normal. Microscopic colitis is a common cause of chronic watery diarrhea and can only be diagnosed histologically.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Hemodynamic instability (hypotension, tachycardia, altered mental status) | EMERGENT | Intravenous access, aggressive fluid resuscitation, consider intensive care unit admission |
| Signs of peritonitis (rigid abdomen, rebound tenderness) | EMERGENT | Surgical consultation, CT abdomen, broad-spectrum antibiotics |
| Severe bloody diarrhea with fever and toxicity | EMERGENT | Hospital admission, stool studies, consider sigmoidoscopy, infectious disease consultation |
| Suspected toxic megacolon (distension, fever, tachycardia) | EMERGENT | Abdominal X-ray, surgical consultation, bowel rest, intravenous steroids if inflammatory bowel disease |
| Moderate dehydration with inability to tolerate oral fluids | URGENT | Intravenous fluids, antiemetics, observation, consider admission if not improving |
| Bloody diarrhea without systemic toxicity | URGENT | Stool studies, inflammatory markers, arrange colonoscopy within 24-48 hours |
| Elderly patient with new diarrhea and abdominal pain | URGENT | Exclude ischemic colitis (CT angiography), check lactate, close monitoring |
| Immunocompromised patient with diarrhea | URGENT | Broad stool workup including opportunistic pathogens, low threshold for admission |
| Acute watery diarrhea, mild dehydration, tolerating oral fluids | ROUTINE | Oral rehydration, symptomatic treatment, safety-net advice, follow-up if not improving in 48-72 hours |
| Chronic diarrhea without alarm features | ROUTINE | Outpatient workup, baseline investigations, consider empiric trials |
Step 2: Classify by Duration
Acute (Less than 14 days)
Most cases: Supportive care only
If alarm features: Proceed to Algorithm A
Key priorities: Hydration, identify red flags, infection control
Persistent (14-30 days)
Consider: Post-infectious irritable bowel syndrome, Giardia, undiagnosed chronic condition
Action: Proceed to Algorithm B
Key priorities: Stool studies, consider empiric treatment
Chronic (Greater than 30 days)
Requires: Systematic workup
Action: Proceed to Algorithm C
Key priorities: Classify stool type, baseline investigations, consider colonoscopy
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Diarrhea with Alarm Features
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Recent antibiotics + watery diarrhea + abdominal pain | Clostridioides difficile infection | Stop inciting antibiotic, send Clostridioides difficile PCR, start oral vancomycin if high suspicion |
| Fever + bloody diarrhea + recent food exposure | Invasive bacterial infection (Salmonella, Shigella, Campylobacter) | Stool culture, consider empiric fluoroquinolone if severe (not if Escherichia coli O157:H7 suspected) |
| Recent travel + watery diarrhea + cramping | Traveler’s diarrhea (enterotoxigenic Escherichia coli, Giardia) | Stool studies including ova and parasites, consider empiric azithromycin or fluoroquinolone |
| Elderly + cardiovascular disease + sudden abdominal pain + bloody stool | Ischemic colitis | CT angiography, lactate, surgical consultation, supportive care |
| Severe dehydration + profuse watery diarrhea + recent shellfish | Vibrio infection or severe viral gastroenteritis | Aggressive fluid resuscitation, stool culture for Vibrio, electrolyte monitoring |
| Multiple people ill after same meal + rapid onset vomiting | Toxin-mediated food poisoning (Staphylococcus aureus, Bacillus cereus) | Supportive care, notify public health if outbreak suspected |
Algorithm B: Persistent Diarrhea (14-30 days)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Post-infectious, bloating, urgency, no blood | Post-infectious irritable bowel syndrome | Reassurance, dietary modification, antidiarrheals, follow-up in 4 weeks |
| Travel history + bloating + flatulence + fatty stools | Giardiasis | Giardia antigen test, treat with metronidazole or tinidazole |
| Started new medication in past month | Drug-induced diarrhea | Trial discontinuation of suspected agent if safe, reassess in 1-2 weeks |
| Worsening symptoms, weight loss, blood appearing | Evolving inflammatory bowel disease or malignancy | Expedite investigations: fecal calprotectin, inflammatory markers, colonoscopy |
Algorithm C: Chronic Diarrhea Workup
Systematic Approach to Chronic Diarrhea:
- Review medications and diet: Eliminate obvious causes (metformin, proton pump inhibitors, excessive caffeine, sugar-free products)
- Classify stool type: Watery (secretory vs osmotic), inflammatory (bloody), or fatty (steatorrhea)
- Order baseline investigations: Complete blood count, metabolic panel, thyroid-stimulating hormone, celiac serology, C-reactive protein, fecal calprotectin
- If alarm features present: Proceed directly to colonoscopy with biopsies
- If no alarm features and watery stool: Consider empiric trials (bile acid sequestrant, lactose elimination)
- If steatorrhea: Check fecal elastase, consider small bowel evaluation
- If investigations negative: Colonoscopy with random biopsies (microscopic colitis), consider small bowel workup
| Stool Characteristics | Primary Considerations | Key Investigations |
|---|---|---|
| Watery, high volume, persists with fasting | Secretory diarrhea: bile acid malabsorption, microscopic colitis, neuroendocrine tumor | Colonoscopy with biopsies, bile acid sequestrant trial, consider 24-hour urine 5-HIAA |
| Watery, stops with fasting | Osmotic diarrhea: lactose intolerance, sorbitol, magnesium | Dietary review, lactose breath test, stool osmotic gap |
| Bloody, mucoid, with urgency | Inflammatory: inflammatory bowel disease, infection, ischemia | Fecal calprotectin, stool culture, colonoscopy with biopsies |
| Pale, greasy, foul-smelling, floats | Steatorrhea: celiac disease, pancreatic insufficiency, small intestinal bacterial overgrowth | Celiac serology, fecal elastase, hydrogen breath test |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on antibiotic develops diarrhea | Assess severity, send Clostridioides difficile test, consider stopping antibiotic if possible | If Clostridioides difficile positive: oral vancomycin or fidaxomicin; if negative: supportive care |
| Clostridioides difficile test positive but patient asymptomatic | Do not treat — this represents colonization, not infection | Only treat formed stool if high-risk (immunocompromised, prior severe Clostridioides difficile) |
| Bloody diarrhea — should I give antibiotics? | Avoid empiric antibiotics until Escherichia coli O157:H7 excluded (risk of hemolytic uremic syndrome) | If severely ill with sepsis: broad-spectrum antibiotics after cultures; otherwise await results |
| Chronic diarrhea with normal colonoscopy | Review biopsy results for microscopic colitis | If biopsies normal: evaluate for small bowel disease, bile acid malabsorption, consider breath testing |
| Patient with inflammatory bowel disease and acute flare | Exclude Clostridioides difficile and cytomegalovirus superinfection | Treat infection if present; if excluded, escalate inflammatory bowel disease therapy |
| Immunocompromised patient with chronic diarrhea | Comprehensive stool panel including opportunistic pathogens (Cryptosporidium, Microsporidium, cytomegalovirus) | Consider colonoscopy with biopsies if stool studies negative; may need multiple specimens |
| Celiac serology positive but patient reluctant for biopsy | Counsel on importance of histological confirmation before lifelong dietary change | If refusing biopsy: check HLA-DQ2/DQ8 (negative excludes celiac), consider trial if high probability |
| Patient requests antidiarrheal for acute bloody diarrhea | Avoid antimotility agents (loperamide) in inflammatory or invasive diarrhea | Safe in non-bloody, non-febrile diarrhea; contraindicated if Clostridioides difficile or dysentery |
| Fecal calprotectin elevated but colonoscopy normal | Ensure biopsies were obtained; review for microscopic colitis | If biopsies normal: consider small bowel Crohn disease (MR enterography or capsule endoscopy) |
| Chronic diarrhea not responding to any treatment | Revisit diagnosis, consider factitious diarrhea (laxative abuse) | Stool laxative screen, stool osmotic gap (very high suggests laxative), psychiatric evaluation if suspected |
Troubleshooting Refractory Diarrhea
Ask These Questions When Diarrhea Persists Despite Treatment
- Is the diagnosis correct? Consider revisiting if no response to appropriate therapy
- Are there multiple overlapping causes? Patients may have inflammatory bowel disease AND bile acid malabsorption, or celiac disease AND small intestinal bacterial overgrowth
- Is treatment compliance adequate? Gluten-free diet requires strict adherence; bile acid sequestrants must be taken consistently
- Was treatment duration sufficient? Some conditions require weeks to months for improvement
- Are there ongoing triggers? Continued medication use, dietary factors, untreated infection
- Is this factitious diarrhea? Consider laxative abuse in refractory cases with high stool osmotic gap
- Has a rare diagnosis been considered? Neuroendocrine tumors, Whipple disease, systemic mastocytosis, amyloidosis
Oral Rehydration: A Key Therapeutic Tool
Oral Rehydration Solution Principles
Oral rehydration therapy exploits the sodium-glucose cotransporter (SGLT1), which remains functional even in secretory diarrhea. The presence of glucose enhances sodium and water absorption.
World Health Organization reduced-osmolarity formula:
- Sodium: 75 mmol/L
- Glucose: 75 mmol/L
- Potassium: 20 mmol/L
- Citrate: 10 mmol/L
- Osmolarity: 245 mOsm/L
Practical alternatives: Commercial oral rehydration solutions (Pedialyte, Hydralyte), or homemade solution (1 liter water + 6 teaspoons sugar + ½ teaspoon salt)
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Big Five” of chronic diarrhea: Irritable bowel syndrome, inflammatory bowel disease, microscopic colitis, celiac disease, and bile acid malabsorption account for the vast majority of cases. Master these conditions first.
Nocturnal diarrhea excludes functional disease: If diarrhea wakes the patient from sleep, this strongly suggests organic pathology and warrants thorough investigation.
Microscopic colitis is invisible: The colonic mucosa appears completely normal on colonoscopy. If you suspect this diagnosis, you must obtain random biopsies from the right and left colon — the diagnosis is histological.
Bile acid malabsorption is underdiagnosed: Up to 30% of patients labeled with diarrhea-predominant irritable bowel syndrome actually have bile acid malabsorption. A therapeutic trial of cholestyramine is both diagnostic and therapeutic.
Fecal calprotectin is an excellent triage tool: A normal fecal calprotectin (less than 50 µg/g) makes inflammatory bowel disease very unlikely and can help avoid unnecessary colonoscopy in young patients without alarm features.
Think postcholecystectomy diarrhea: Always ask about prior cholecystectomy in patients with chronic watery diarrhea. Bile acid malabsorption following gallbladder removal is common and very treatable.
Check total IgA when ordering celiac serology: Approximately 2-3% of celiac patients are IgA deficient, which causes false-negative tissue transglutaminase IgA results. If IgA is low, order deamidated gliadin peptide IgG.
Medication review is essential: Always review the medication list thoroughly. Metformin, proton pump inhibitors, nonsteroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, and magnesium supplements are common culprits.
Critical Pitfalls to Avoid
Testing asymptomatic patients for Clostridioides difficile: Do not send Clostridioides difficile PCR on formed stool. Asymptomatic carriage is common, and a positive result in a patient without diarrhea represents colonization, not infection. Only test unformed stool.
Giving antibiotics for bloody diarrhea before excluding Escherichia coli O157:H7: Antibiotics may increase the risk of hemolytic uremic syndrome in Shiga toxin-producing Escherichia coli infection. Avoid empiric antibiotics in bloody diarrhea until this is excluded.
Using loperamide in inflammatory or infectious diarrhea: Antimotility agents are contraindicated in Clostridioides difficile infection, dysentery, and severe inflammatory bowel disease flares. They may precipitate toxic megacolon or prolong infection.
Starting a gluten-free diet before completing celiac workup: Once gluten is eliminated, serologies may normalize and biopsies may heal, making diagnosis impossible. Complete all testing before dietary modification.
Performing colonoscopy without biopsies: A macroscopically normal colonoscopy does not exclude microscopic colitis. Always obtain random biopsies from right and left colon in chronic diarrhea, regardless of mucosal appearance.
Assuming diarrhea in elderly equals infection: Ischemic colitis is a common cause of acute bloody diarrhea in elderly patients with cardiovascular disease. Missing this diagnosis can have serious consequences. Maintain high clinical suspicion.
Forgetting about overflow diarrhea: In elderly or immobile patients, apparent diarrhea may actually be liquid stool bypassing a fecal impaction. Always perform a rectal examination to exclude impaction.
Ignoring the duration of antibiotic exposure: Clostridioides difficile can occur during antibiotic treatment or up to 3 months afterward. Ask about antibiotic use in the past 3 months, not just current medications.
Key Takeaways
- Classify diarrhea by duration first: acute (less than 14 days), persistent (14-30 days), or chronic (greater than 30 days) — this determines the approach
- Most acute diarrhea is viral and self-limiting; investigation is only needed when alarm features are present
- The four mechanisms of diarrhea are secretory, osmotic, inflammatory, and motility-related — understanding these guides diagnosis and treatment
- Always ask about recent antibiotic use, new medications, travel, food exposures, and surgical history (especially cholecystectomy and ileal resection)
- Red flags requiring urgent evaluation include bloody stool, high fever, severe dehydration, severe abdominal pain, and immunocompromised status
- Fecal calprotectin is an excellent non-invasive test to distinguish inflammatory from functional diarrhea and guide colonoscopy referral
- Normal colonoscopy appearance does not exclude microscopic colitis — always obtain biopsies in chronic diarrhea workup
- Bile acid malabsorption is underdiagnosed; consider a therapeutic trial of cholestyramine in watery diarrhea, especially postcholecystectomy
- Multiple causes may coexist — patients with inflammatory bowel disease can have superimposed Clostridioides difficile infection or bile acid malabsorption
- Oral rehydration is the cornerstone of acute diarrhea management; intravenous fluids are reserved for severe dehydration or inability to tolerate oral intake
Quick Reference Algorithm
Systematic Approach to Diarrhea:
- Assess urgency: Check vital signs, hydration status, and red flags — stabilize if hemodynamically compromised
- Classify by duration: Acute, persistent, or chronic — this determines investigation strategy
- Characterize the stool: Watery, bloody/inflammatory, or fatty — this narrows the differential
- Take a focused history: Use the “DIARRHEA” mnemonic — medications, diet, travel, exposures, associated symptoms
- Perform targeted examination: Focus on hydration, nutrition, abdominal findings, and rectal examination
- Order appropriate investigations: Baseline tests for chronic diarrhea; targeted tests based on clinical suspicion
- Consider empiric treatment trials: Bile acid sequestrant, lactose elimination, or antibiotics for small intestinal bacterial overgrowth when diagnosis is uncertain
- Escalate if needed: Colonoscopy with biopsies for persistent symptoms, alarm features, or elevated fecal calprotectin
- Treat the underlying cause: Specific therapy directed at the identified etiology
- Follow up: Reassess response, consider alternative diagnoses if not improving, address nutritional consequences
Quick Reference: Common Scenarios
| Scenario | Key Action |
|---|---|
| Acute watery diarrhea, healthy adult, no alarm features | Supportive care, oral rehydration, no investigation needed |
| Diarrhea after recent antibiotics | Test for Clostridioides difficile, stop inciting antibiotic if possible |
| Chronic watery diarrhea with normal colonoscopy | Ensure biopsies obtained; consider bile acid malabsorption trial |
| Steatorrhea with weight loss | Check celiac serology and fecal elastase |
| Bloody diarrhea with fever | Stool cultures, avoid antibiotics until Escherichia coli O157:H7 excluded |
| Chronic diarrhea in patient with diabetes | Consider metformin effect, diabetic enteropathy, small intestinal bacterial overgrowth |
| Diarrhea postcholecystectomy | Trial of bile acid sequestrant (cholestyramine) |
| Elderly patient with sudden bloody diarrhea and abdominal pain | Consider ischemic colitis, CT angiography, surgical consultation |